Lévy, Yves <br/><br/>
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.  [electronic resource] 

 -  Annals of internal medicine  03 2020 
 - 297-305 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1539-3704 
<br/><br/><label>Standard No.: </label>10.7326/M19-2133  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-HIV Agents--administration & dosage<br/>Antiretroviral Therapy, Highly Active--methods<br/>CD4 Lymphocyte Count<br/>Double-Blind Method<br/>Female<br/>HIV Fusion Inhibitors--administration & dosage<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Maraviroc--administration & dosage<br/>Middle Aged<br/>Treatment Outcome<br/>Viral Load--drug effects<br/>Young Adult